Australia markets closed

Marinus Pharmaceuticals, Inc. (MRNS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.5100+0.0600 (+4.14%)
At close: 04:00PM EDT
1.5198 +0.01 (+0.65%)
After hours: 07:58PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
120,572
240,551
122,927
138,509
Other short-term investments
29,716
0
0
1,474
Total cash
150,288
240,551
122,927
139,983
Net receivables
3,799
6,348
2,629
1,646
Inventory
2,413
77
0
-
Other current assets
8,746
5,402
5,565
4,638
Total current assets
165,246
252,378
131,678
146,267
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
5,743
5,690
3,893
3,077
Accumulated depreciation
-1,900
-1,454
-1,394
-1,132
Net property, plant and equipment
3,843
4,236
2,499
1,945
Other long-term assets
1,819
2,904
2,663
2,250
Total non-current assets
5,662
7,140
5,162
4,195
Total assets
170,908
259,518
136,840
150,462
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
11,551
1,020
-
-
Accounts payable
4,003
4,461
3,126
2,211
Accrued liabilities
22,085
16,454
15,651
8,008
Other current liabilities
-
-
21,233
-
Total current liabilities
40,624
25,017
40,566
10,729
Non-current liabilities
Long-term debt
61,423
71,018
40,809
-
Deferred revenues
17,545
16,285
0
-
Other long-term liabilities
785
1,341
-
2,534
Total non-current liabilities
113,519
118,501
42,788
2,534
Total liabilities
154,143
143,518
83,354
13,263
Stockholders' equity
Common stock
55
4,093
4,339
4,506
Retained earnings
-571,926
-430,521
-410,705
-311,929
Accumulated other comprehensive income
-20
0
-
-
Total stockholders' equity
16,765
116,000
53,486
137,199
Total liabilities and stockholders' equity
170,908
259,518
136,840
150,462